It has been another busy year for M&A in health tech and life sciences, from Allscripts acquisition of specialty drug platform , UnitedHealth Group’s purchase of PatientsLikeMe, JP Morgan’s acquisition of medical billing business InstaMed, Bristol-Myers Squibb’s deal to buy Celgene and Google’s acquisition of Fitbit.
The interest in tools to support social determinants of health to improve patient access to healthier dietary options and transport to their appointments has increased as payers and providers see them as a way to help people manage chronic conditions and reduce the need for emergency hospitalization.
Where will strategic investors prioritize investments in 2020? How much further do AI tools need to advance to improve automation in healthcare? What are some of the collaborations that will help advance population health?
As you plan for the coming year, we would encourage you to include these MedCity events as you review where to allocate your sponsorship and advertising funds in 2020. They are also fantastic opportunities to take part in conversations around vital topics in healthcare, hear pitches from exciting healthcare startups and, of course, network.
When? April 21-22
Where? Chicago Ritz Carlton
The agenda for INVEST is filled with hot topics in healthcare innovation from digital therapeutics, a debate on the merits of AI in healthcare, games in healthcare and more. Check out the preliminary agenda here. For more information about sponsorship opportunities, click here.
When? May 19
Where? New Orleans
The preliminary agenda for this conference spotlights a variety of issues that touch on population health. It will also provide a platform for startups that have developed tools to address chronic disease to talk about how they are taking on this challenge. For more information on sponsorship opportunities for this event, click here.
INVEST Precision Medicine (formerly CONVERGE)
When? June 25, 2020
Where? Philadelphia, University City Science Center
This preliminary agenda for this conference explores the intersection of health IT and biopharma from the use of digital health tools to identify drug development targets to new developments in clinical trial design. The advancement of gene therapy presents exciting prospects to treat and even cure common and rare diseases. The daylong conference will also address complexities of how to navigate wider adoption of precision medicine therapies from reimbursement to manufacturing and more. For sponsorship opportunities, click here.
When? September 2020
Where? Minneapolis
This conference, in association with Medical Alley, brings together active investors with corporate business development executives to facilitate investment opportunities with the most innovative companies from the digital health sector. Stay tuned for a preliminary agenda. For information on sponsorship opportunities, click here.
Photo: Rawpixel, Getty Images
